Frontotemporal Degeneration: Clinical Trials

1 trial for Frontotemporal Degeneration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Frontotemporal Degeneration: new trials by email Literature Review of Frontotemporal Degeneration trials Research Report on Frontotemporal Degeneration

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Vortioxetine - Fronto-temporal Dementia, Fronto-temporal Lobar Dementia
Phase 2RecruitingJohns Hopkins University502025-03-202026-03-09

Narrower conditions

Frontotemporal Dementia (1)  ·  Pick Disease of the Brain (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)  ·  TDP-43 Proteinopathies (1)

Interventions

Vortioxetine (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

Christopher Morrow, MD (1)

NIH funding

K23AG088248 (1)